Xiaoli Chen

Chongqing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Longitudinal Interferon-γ Release Assay Changes in Psoriasis Treated With Interleukin Inhibitors: A Single-Center Real-World Cohort Study in China.

Longitudinal Interferon-γ Release Assay Changes in Psoriasis Treated With Interleukin Inhibitors: A Single-Center Real-World Cohort Study in China.

Journal: Journal of the American Academy of Dermatology

Published: April 07, 2026

Abrocitinib Treatment of Atopic Dermatitis or Eczema in Patients with Coexistent or Prior Psoriasis: Three Cases with Literature Review.

Abrocitinib Treatment of Atopic Dermatitis or Eczema in Patients with Coexistent or Prior Psoriasis: Three Cases with Literature Review.

Journal: Clinical, cosmetic and investigational dermatology

Published: December 08, 2025

A 76-week real-world multidimensional analysis of guselkumab in moderate to severe plaque psoriasis: a retrospective cohort study based on Chinese clinical practice standards.

A 76-week real-world multidimensional analysis of guselkumab in moderate to severe plaque psoriasis: a retrospective cohort study based on Chinese clinical practice standards.

Journal: Frontiers in immunology

Published: August 13, 2025

One Man's Meat Is Another Man's Poison: High Incidence of Severe Cutaneous Drug Reactions Induced by Enfortumab Vedotin.

One Man's Meat Is Another Man's Poison: High Incidence of Severe Cutaneous Drug Reactions Induced by Enfortumab Vedotin.

Journal: European urology open science

Published: August 01, 2025

Dual Biologic Therapy for Psoriasis in a Patient with Atopic Dermatitis.

Dual Biologic Therapy for Psoriasis in a Patient with Atopic Dermatitis.

Journal: Psoriasis (Auckland, N.Z.)

Published: January 11, 2025

Successful Guselkumab Treatment in a Patient with Comorbid Psoriasis and Amyotrophic Lateral Sclerosis: A Case Study and Literature Review.

Successful Guselkumab Treatment in a Patient with Comorbid Psoriasis and Amyotrophic Lateral Sclerosis: A Case Study and Literature Review.

Journal: Clinical, cosmetic and investigational dermatology

Published: November 27, 2024

Successful guselkumab treatment of a refractory psoriasis patient with Graves' disease: a case report.

Successful guselkumab treatment of a refractory psoriasis patient with Graves' disease: a case report.

Journal: The Journal of international medical research

Published: April 24, 2024

Herpes Zoster Ophthalmicus Clinical Presentation and Risk Factors for Lesion Recovery.

Herpes Zoster Ophthalmicus Clinical Presentation and Risk Factors for Lesion Recovery.

Journal: Clinical, cosmetic and investigational dermatology

Published: October 15, 2023

Platelet-to-lymphocyte ratio predicts the duration of glucocorticoid therapy in the treatment of cutaneous adverse drug reactions.

Platelet-to-lymphocyte ratio predicts the duration of glucocorticoid therapy in the treatment of cutaneous adverse drug reactions.

Journal: Toxicology and applied pharmacology

Published: November 26, 2022

Clinical observation and study of local hyperthermia for treating plantar warts: A pilot study with 38 patients.

Clinical observation and study of local hyperthermia for treating plantar warts: A pilot study with 38 patients.

Journal: Frontiers in medicine

Published: November 02, 2022

Characteristics of cutaneous adverse drug reactions with special respect to the incubation period based on hospitalized patients.

Characteristics of cutaneous adverse drug reactions with special respect to the incubation period based on hospitalized patients.

Journal: Anais brasileiros de dermatologia

Published: April 04, 2022

Showing 1-11 of 11

Last Updated: 09/26/2026